Numerous clinical and epidemiological investigations have consistently shown elevated levels of plasma inflammatory markers (59), such as C-reactive protein (60), high-sensitivity C-reactive protein (61), and interleukin-6 (62) in DKD patients. This evidence concerns the gene CRP and diabetic kidney disease.